These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846 [TBL] [Abstract][Full Text] [Related]
3. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'. Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987 [TBL] [Abstract][Full Text] [Related]
4. [Recent advances in isolation and detection of circulating tumor cells with a microfluidic system]. Cao R; Zhang M; Yu H; Qin J Se Pu; 2022 Mar; 40(3):213-223. PubMed ID: 35243831 [TBL] [Abstract][Full Text] [Related]
5. A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells. Casavant BP; Mosher R; Warrick JW; Maccoux LJ; Berry SM; Becker JT; Chen V; Lang JM; McNeel DG; Beebe DJ Methods; 2013 Dec; 64(2):137-43. PubMed ID: 23806645 [TBL] [Abstract][Full Text] [Related]
6. An integrated microfluidic chip system for single-cell secretion profiling of rare circulating tumor cells. Deng Y; Zhang Y; Sun S; Wang Z; Wang M; Yu B; Czajkowsky DM; Liu B; Li Y; Wei W; Shi Q Sci Rep; 2014 Dec; 4():7499. PubMed ID: 25511131 [TBL] [Abstract][Full Text] [Related]
7. SSA-MOA: a novel CTC isolation platform using selective size amplification (SSA) and a multi-obstacle architecture (MOA) filter. Kim MS; Sim TS; Kim YJ; Kim SS; Jeong H; Park JM; Moon HS; Kim SI; Gurel O; Lee SS; Lee JG; Park JC Lab Chip; 2012 Aug; 12(16):2874-80. PubMed ID: 22684249 [TBL] [Abstract][Full Text] [Related]
8. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648 [TBL] [Abstract][Full Text] [Related]
9. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508 [TBL] [Abstract][Full Text] [Related]
10. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126 [TBL] [Abstract][Full Text] [Related]
11. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen. Johnson ES; Anand RK; Chiu DT Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174 [TBL] [Abstract][Full Text] [Related]
12. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low. Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851 [TBL] [Abstract][Full Text] [Related]
13. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs). Hyun KA; Lee TY; Lee SH; Jung HI Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749 [TBL] [Abstract][Full Text] [Related]
14. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device. Galletti G; Sung MS; Vahdat LT; Shah MA; Santana SM; Altavilla G; Kirby BJ; Giannakakou P Lab Chip; 2014 Jan; 14(1):147-56. PubMed ID: 24202699 [TBL] [Abstract][Full Text] [Related]
15. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Lin M; Chen JF; Lu YT; Zhang Y; Song J; Hou S; Ke Z; Tseng HR Acc Chem Res; 2014 Oct; 47(10):2941-50. PubMed ID: 25111636 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition. Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372 [TBL] [Abstract][Full Text] [Related]
17. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System. Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728 [TBL] [Abstract][Full Text] [Related]
18. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer. Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200 [TBL] [Abstract][Full Text] [Related]
19. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination-free flow cytometry. Takao M; Takeda K Cytometry A; 2011 Feb; 79(2):107-17. PubMed ID: 21246706 [TBL] [Abstract][Full Text] [Related]
20. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells. Khoo BL; Warkiani ME; Tan DS; Bhagat AA; Irwin D; Lau DP; Lim AS; Lim KH; Krisna SS; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT PLoS One; 2014; 9(7):e99409. PubMed ID: 24999991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]